COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
June 2015

24

June
2015

FDA Releases New Guidance for Compounding Animal Drugs from Bulk Drug Substances

June 24, 2015 Animal Compounders Fear the End is Near & Begin to Fight Their Losing Battle A few weeks ago the FDA released their latest guidance, #230 Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances and animal compounders are very concerned at what this means for their futures. All guidances reflect the […]

read more

9

June
2015

category:

503b Compounding

Ophthalmologists and Patients Demand Quality Compounded Drugs at Affordable Prices

Access to compounding medications critical for ophthalmologists, patients http://www.healio.com/ophthalmology/practice-management/news/print/ocular-surgery-news/%7Bebef4371-1c0c-460d-b3cb-6e8d524915e2%7D/access-to-compounded-medications-critical-for-ophthalmologists-patients?page=1 Ocular Surgery News U.S. Edition, May 25, 2015 Richard L. Lindstrom, MD The decisions the FDA makes are critical to ophthalmologists and patients, especially in the anti-VEGF category. As I mentioned above, no generic anti-VEGF injectables are available. Lucentis (ranibizumab, Genentech) and Eylea, branded and patent-protected […]

read more